» Articles » PMID: 33843464

Pathogenicity and Virulence of Hepatitis A Virus

Overview
Journal Virulence
Specialty Microbiology
Date 2021 Apr 12
PMID 33843464
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis A is an acute infection of the liver, which is mostly asymptomatic in children and increases the severity with age. Although in most patients the infection resolves completely, in a few of them it may follow a prolonged or relapsed course or even a fulminant form. The reason for these different outcomes is unknown, but it is generally accepted that host factors such as the immunological status, age and the occurrence of underlaying hepatic diseases are the main determinants of the severity. However, it cannot be ruled out that some virus traits may also contribute to the severe clinical outcomes. In this review, we will analyze which genetic determinants of the virus may determine virulence, in the context of a paradigmatic virus in terms of its genomic, molecular, replicative, and evolutionary features.

Citing Articles

Enhanced replication of a hepatitis A virus vaccine strain via adaptation in Vero cells.

Seo S, Choi J, Kim M, Yang E, Choi S, Seo D Clin Exp Vaccine Res. 2025; 14(1):10-22.

PMID: 39927228 PMC: 11799578. DOI: 10.7774/cevr.2025.14.e10.


Vaccination status and hepatitis A immunity in children: insights from a large-scale study in Turkey.

Yigit M, Kalayci F BMC Infect Dis. 2025; 25(1):61.

PMID: 39810097 PMC: 11734540. DOI: 10.1186/s12879-025-10458-9.


Current knowledge on the epidemiology and detection methods of hepatitis E virus in China.

Duan B, Feng Y Virol J. 2024; 21(1):307.

PMID: 39593111 PMC: 11590246. DOI: 10.1186/s12985-024-02576-8.


A Useful Method to Provide Infectious and Cultivable In Vitro Naked Viral Particles of Hepatitis A Virus.

Verbrugghe G, Soudan-Foulques C, Fraisse A, Waldman Vigne P, Perelle S, Ndoye F Viruses. 2024; 16(9).

PMID: 39339837 PMC: 11435643. DOI: 10.3390/v16091360.


Mapping disparities in viral infection rates using highly multiplexed serology.

Pina A, Elko E, Caballero R, Metrailer M, Mulrow M, Quan D mSphere. 2024; 9(9):e0012724.

PMID: 39162531 PMC: 11423740. DOI: 10.1128/msphere.00127-24.


References
1.
Yang Y, Liang Y, Qu L, Chen Z, Yi M, Li K . Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci U S A. 2007; 104(17):7253-8. PMC: 1855380. DOI: 10.1073/pnas.0611506104. View

2.
Hirai-Yuki A, Hensley L, McGivern D, Gonzalez-Lopez O, Das A, Feng H . MAVS-dependent host species range and pathogenicity of human hepatitis A virus. Science. 2016; 353(6307):1541-1545. PMC: 5068972. DOI: 10.1126/science.aaf8325. View

3.
McKnight K, Xie L, Gonzalez-Lopez O, Rivera-Serrano E, Chen X, Lemon S . Protein composition of the hepatitis A virus quasi-envelope. Proc Natl Acad Sci U S A. 2017; 114(25):6587-6592. PMC: 5488923. DOI: 10.1073/pnas.1619519114. View

4.
Alizon S, Hurford A, Mideo N, van Baalen M . Virulence evolution and the trade-off hypothesis: history, current state of affairs and the future. J Evol Biol. 2009; 22(2):245-59. DOI: 10.1111/j.1420-9101.2008.01658.x. View

5.
Aragones L, Guix S, Ribes E, Bosch A, Pinto R . Fine-tuning translation kinetics selection as the driving force of codon usage bias in the hepatitis A virus capsid. PLoS Pathog. 2010; 6(3):e1000797. PMC: 2832697. DOI: 10.1371/journal.ppat.1000797. View